HHS In role
Abe Sutton
Deputy Administrator and Director, CMS Innovation Center (CMMI)
Attorney (Harvard Law) and health-care founder serving since January 2025 as Deputy Administrator and Director of the CMS Innovation Center (CMMI). He decides which federal payment models live, die, or scale — and has remade the portfolio around downside risk, prevention, and competition, from the WISeR prior-authorization model to the BALANCE GLP-1 coverage model.
Role status — October 2026: Sutton is the Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation, in the role since January 2025. CMS’s own June 2026 update to the Innovation Center’s About page states the center “is directed by Abe Sutton,” and he remains its public face through 2026.
Sutton is a second-tour Trump health official. From 2017 to 2019 he worked health policy at the National Economic Council, the Domestic Policy Council, and HHS, coordinating cross-government work on paying for value in Medicare, market competition, and kidney care. Between tours he was a principal at Rubicon Founders, where he co-founded two health-services companies: Honest Health, which supports primary care physicians, and Evergreen Nephrology, which supports nephrologists. He holds a law degree from Harvard and undergraduate degrees from the University of Pennsylvania’s Wharton School and College.
His record is a deliberate portfolio reset. In March 2025, CMMI announced early terminations of four models — Primary Care First, Making Care Primary, the mandatory ESRD Treatment Choices model, and Maryland Total Cost of Care — and dropped two more initiatives, with CMMI estimating roughly $750 million in taxpayer savings. In May 2025 he published the center’s new strategy: evidence-based prevention, empowering patients, and choice and competition, with a hard rule that every alternative payment model must involve downside risk. The builds since then are his own: WISeR, a six-year model (2026–2031) using AI-assisted technology to expedite prior authorization for specified low-value services; ACCESS, a voluntary ten-year model paying for technology-supported chronic care on outcomes, starting July 2026; BALANCE, a voluntary model letting Part D plans and Medicaid programs cover GLP-1s at CMS-negotiated prices; and ASPIRE, an ACO-style model for high-risk children in Medicaid.
Why tracked here: CMMI is where Medicare and Medicaid payment policy gets tested before it becomes permanent, and Sutton is deciding — model by model — what survives of the last decade’s value-based-care experiment and what replaces it.
Sources (Oct 2026): CMS leadership, Innovation Center About, and strategy pages; Holland & Knight, March 2025; Becker’s Payer, May 14, 2025; Healthcare Dive, July 1, 2025; Fierce Healthcare, Dec. 24, 2025; AMA, March 25, 2026.